Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma Di Carlo

Showing results (51-60 of 94) with videos related to

Pageof 10
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 2010
Interleukin-27 acts as multifunctional antitumor agent in multiple myelomaClaudia Cocco, Nicola Giuliani, Emma Di Carlo, et al.
Oncotarget|June 26, 2015
The MUTYH base excision repair gene protects against inflammation-associated colorectal carcinogenesisFrancesca Grasso, Serena Di Meo, Gabriele De Luca, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2012
Interleukin-27 inhibits the growth of pediatric acute myeloid leukemia in NOD/SCID/Il2rg-/- miceAlessia Zorzoli, Emma Di Carlo, Claudia Cocco, et al.
Cancer Research|February 12, 2005
Inhibition of mammary carcinoma development in HER-2/neu transgenic mice through induction of autoimmunity by xenogeneic DNA vaccinationSerenella M Pupa, Manuela Iezzi, Emma Di Carlo, et al.
Experimental & Molecular Medicine|September 4, 2024
Immunoliposome-based targeted delivery of the CRISPR/Cas9gRNA-IL30 complex inhibits prostate cancer and prolongs survivalCristiano Fieni, Carlo Sorrentino, Stefania Livia Ciummo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 6, 2006
Timely DNA vaccine combined with systemic IL-12 prevents parotid carcinomas before a dominant-negative p53 makes their growth independent of HER-2/neu expressionTania Pannellini, Michela Spadaro, Emma Di Carlo, et al.
Oncotarget|December 25, 2015
Genetic deletion of osteopontin in TRAMP mice skews prostate carcinogenesis from adenocarcinoma to aggressive human-like neuroendocrine cancersGiorgio Mauri, Elena Jachetti, Barbara Comuzzi, et al.
Oncotarget|November 6, 2015
SOX2 boosts major tumor progression genes in prostate cancer and is a functional biomarker of lymph node metastasisMarco Vincenzo Russo, Silvia Esposito, Maria Grazia Tupone, et al.
Blood|August 6, 2005
Lack of Il12rb2 signaling predisposes to spontaneous autoimmunity and malignancyIrma Airoldi, Emma Di Carlo, Claudia Cocco, et al.
Cancer Research|November 1, 2008
Macrophage-derived SPARC bridges tumor cell-extracellular matrix interactions toward metastasisSabina Sangaletti, Emma Di Carlo, Silvia Gariboldi, et al.
Pageof 10

Showing results (51-60 of 94) with videos related to

Sort By:
Pageof 10
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 2010
Interleukin-27 acts as multifunctional antitumor agent in multiple myelomaClaudia Cocco, Nicola Giuliani, Emma Di Carlo, et al.
Oncotarget|June 26, 2015
The MUTYH base excision repair gene protects against inflammation-associated colorectal carcinogenesisFrancesca Grasso, Serena Di Meo, Gabriele De Luca, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2012
Interleukin-27 inhibits the growth of pediatric acute myeloid leukemia in NOD/SCID/Il2rg-/- miceAlessia Zorzoli, Emma Di Carlo, Claudia Cocco, et al.
Cancer Research|February 12, 2005
Inhibition of mammary carcinoma development in HER-2/neu transgenic mice through induction of autoimmunity by xenogeneic DNA vaccinationSerenella M Pupa, Manuela Iezzi, Emma Di Carlo, et al.
Experimental & Molecular Medicine|September 4, 2024
Immunoliposome-based targeted delivery of the CRISPR/Cas9gRNA-IL30 complex inhibits prostate cancer and prolongs survivalCristiano Fieni, Carlo Sorrentino, Stefania Livia Ciummo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 6, 2006
Timely DNA vaccine combined with systemic IL-12 prevents parotid carcinomas before a dominant-negative p53 makes their growth independent of HER-2/neu expressionTania Pannellini, Michela Spadaro, Emma Di Carlo, et al.
Oncotarget|December 25, 2015
Genetic deletion of osteopontin in TRAMP mice skews prostate carcinogenesis from adenocarcinoma to aggressive human-like neuroendocrine cancersGiorgio Mauri, Elena Jachetti, Barbara Comuzzi, et al.
Oncotarget|November 6, 2015
SOX2 boosts major tumor progression genes in prostate cancer and is a functional biomarker of lymph node metastasisMarco Vincenzo Russo, Silvia Esposito, Maria Grazia Tupone, et al.
Blood|August 6, 2005
Lack of Il12rb2 signaling predisposes to spontaneous autoimmunity and malignancyIrma Airoldi, Emma Di Carlo, Claudia Cocco, et al.
Cancer Research|November 1, 2008
Macrophage-derived SPARC bridges tumor cell-extracellular matrix interactions toward metastasisSabina Sangaletti, Emma Di Carlo, Silvia Gariboldi, et al.
Pageof 10